Page last updated: 2024-10-24

carmustine and Cerebral Hemorrhage

carmustine has been researched along with Cerebral Hemorrhage in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagahiro, S1
Yamamoto, YL1
Diksic, M1
Mitsuka, S1
Sugimoto, S1
Feindel, W1

Other Studies

1 other study available for carmustine and Cerebral Hemorrhage

ArticleYear
Neurotoxicity after intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea administration in the rat: hemodynamic changes studied by double-tracer autoradiography.
    Neurosurgery, 1991, Volume: 29, Issue:1

    Topics: Aminobutyrates; Amygdala; Animals; Antipyrine; Autoradiography; Blood-Brain Barrier; Carbon Radioiso

1991